We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.69%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$44.8B
AUM Growth
+$2.56B
(+6%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
3.76%
Top 10 Holdings %
Top 10 Hldgs %
16.87%
Holding
1,943
New
239
Increased
582
Reduced
502
Closed
593
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$610M |
| 2 |
Oracle
ORCL
|
+$367M |
| 3 |
TSMC
TSM
|
+$365M |
| 4 |
PayPal
PYPL
|
+$355M |
| 5 |
Nike
NKE
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$507M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$248M |
| 3 |
Home Depot
HD
|
+$214M |
| 4 |
GSK
GSK
|
+$190M |
| 5 |
Novartis
NVS
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Financials | 20.3% |
| 3 | Healthcare | 17.12% |
| 4 | Consumer Discretionary | 13.56% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$469B
| $1.28B | 2.85% |
4,826,210
+871,010
| +22% | +$218M |
|
|
2
Visa
V
$669B
| $1.17B | 2.61% |
6,732,050
+3,724,588
| +124% | +$610M |
|
3
Merck
MRK
$322B
| $775M | 1.73% |
9,681,640
+1,705,671
| +21% | +$131M |
|
4
Rio Tinto
RIO
$149B
| $736M | 1.64% |
11,800,576
-1,126,098
| -9% | -$67.5M |
|
5
IBM
IBM
$195B
| $734M | 1.64% |
5,570,040
+450,844
| +9% | +$59.2M |
|
6
Starbucks
SBUX
$118B
| $667M | 1.49% |
7,953,188
+3,599,256
| +83% | +$282M |
|
7
Biogen
BIIB
$29.6B
| $583M | 1.3% |
2,494,757
+778,167
| +45% | +$180M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $564M | 1.26% |
6,102,398
+294,508
| +5% | +$28M |
|
9
AbbVie
ABBV
$454B
| $538M | 1.2% |
7,398,934
+483,145
| +7% | +$38M |
|
10
Intel
INTC
$504B
| $523M | 1.17% |
10,930,470
+1,471,136
| +16% | +$72.9M |
|
11
Union Pacific
UNP
$181B
| $494M | 1.1% |
2,923,861
+641,107
| +28% | +$110M |
|
|
12
PayPal
PYPL
$49.4B
| $485M | 1.08% |
4,241,186
+3,205,425
| +309% | +$355M |
|
13
TJX Companies
TJX
$170B
| $483M | 1.08% |
9,128,765
-3,258,933
| -26% | -$173M |
|
14
HCA Healthcare
HCA
$83.5B
| $467M | 1.04% |
3,451,261
-588,108
| -15% | -$74.4M |
|
15
Automatic Data Processing
ADP
$97.1B
| $466M | 1.04% |
2,818,888
+639,489
| +29% | +$104M |
|
16
Canadian National Railway
CNI
$79.2B
| $451M | 1.01% |
4,872,344
+1,216,067
| +33% | +$112M |
|
17
Adobe
ADBE
$84.3B
| $448M | 1% |
1,519,442
-542,529
| -26% | -$151M |
|
|
18
TSMC
TSM
$2.16T
| $442M | 0.98% |
11,277,172
+8,875,126
| +369% | +$365M |
|
19
Intuit
INTU
$77B
| $440M | 0.98% |
1,682,032
+291,011
| +21% | +$74M |
|
20
UnitedHealth
UNH
$385B
| $429M | 0.96% |
1,759,979
+32,680
| +2% | +$7.86M |
|
|
21
Bristol-Myers Squibb
BMY
$126B
| $427M | 0.95% |
9,419,215
-5,319,461
| -36% | -$248M |
|
22
Boeing
BA
$165B
| $415M | 0.93% |
1,140,440
-179,851
| -14% | -$65.6M |
|
|
23
Oracle
ORCL
$346B
| $405M | 0.9% |
7,109,540
+6,779,807
| +2,056% | +$367M |
|
24
AstraZeneca
AZN
$261B
| $387M | 0.86% |
4,682,780
-1,546,904
| -25% | -$121M |
|
25
Comcast
CMCSA
$78.3B
| $386M | 0.86% |
9,130,351
+6,670,928
| +271% | +$281M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Arrowstreet Capital held 1,943 positions worth $44.8B, up 6% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Arrowstreet Capital deployed $1.69B of net new capital in Q2 2019, opening 239 new positions and adding to 582 existing holdings. Its largest new stake was Ralph Lauren: 728,713 shares worth $82.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI South Korea ETF, an estimated $507M trimmed.
- Arrowstreet Capital's largest Q2 2019 buy was Ralph Lauren: 728,713 shares worth $82.8M.
- Arrowstreet Capital added most to Visa in Q2 2019, an estimated $610M increase.
- Arrowstreet Capital's biggest Q2 2019 reduction was iShares MSCI South Korea ETF, cutting an estimated $507M.
- Arrowstreet Capital fully exited Advanced Micro Devices in Q2 2019, selling an estimated $116M.
- Arrowstreet Capital's ten largest holdings make up 17% of its $44.8B portfolio in Q2 2019.
- Arrowstreet Capital opened 239 new positions and closed 593 in Q2 2019.
- Arrowstreet Capital's portfolio value rose 6% quarter-over-quarter to $44.8B.
Based on Arrowstreet Capital's 13F filing for Q2 2019, filed 14 Aug 2019.